Figure 6
Figure 6. CCR7−/− HSCs and MPCs exhibit enhanced myeloid reconstitution, compared with WT cells during IA after a competitive reconstitution transplantation. (A) Experimental scheme in which WT CD45.1 mice were lethally irradiated and reconstituted with 3.0 × 102 HSCs, 5.0 × 103 CMPs, and 5.0 × 103 GMPs from CD45.2 WT GFP+ and CCR7−/− mice. Fourteen days after HSCT, mice were challenged with 2.0 × 106 conidia and cells were analyzed by flow cytometry 48 hours later. (B) Percent of total, (WT and CCR7−/−) donor neutrophils or DCs in the lungs of chimeric mice after conidial challenge (gray bars) and the percentage of donor cells derived from WT or CCR7−/− mice (white and black bars, respectively). (C) Contour plots showing donor-derived DCs from WT GFP+ or CCR7−/− mice (n = 5 mice, representative of 2 experiments). *P < .05, when comparing GFP+ and CCR7−/− donor cells after HSCT.

CCR7−/− HSCs and MPCs exhibit enhanced myeloid reconstitution, compared with WT cells during IA after a competitive reconstitution transplantation. (A) Experimental scheme in which WT CD45.1 mice were lethally irradiated and reconstituted with 3.0 × 102 HSCs, 5.0 × 103 CMPs, and 5.0 × 103 GMPs from CD45.2 WT GFP+ and CCR7−/− mice. Fourteen days after HSCT, mice were challenged with 2.0 × 106 conidia and cells were analyzed by flow cytometry 48 hours later. (B) Percent of total, (WT and CCR7−/−) donor neutrophils or DCs in the lungs of chimeric mice after conidial challenge (gray bars) and the percentage of donor cells derived from WT or CCR7−/− mice (white and black bars, respectively). (C) Contour plots showing donor-derived DCs from WT GFP+ or CCR7−/− mice (n = 5 mice, representative of 2 experiments). *P < .05, when comparing GFP+ and CCR7−/− donor cells after HSCT.

Close Modal

or Create an Account

Close Modal
Close Modal